Social Sciences · Safety Research
Una cita con poco brillo: Así fue... ENERGY ASIA 2006
See on the mapAbstract
These results appear to be better than those reported for conventional-dose salvage chemotherapy. High-dose therapy followed by autologous bone marrow or peripheral blood stem cell transplantation should be considered for any patient with relapsed Hodgkin's disease, regardless of the length of initial remission, or type of initial chemotherapy. Certain patients, especially those with minimal disease, may benefit by proceeding directly to transplantation after relapse, without first receiving conventional-dose salvage chemotherapy.
More like this
Autogreffe de cellules souches hématopoïétiques périphériques dans le cadre du traitement d'hémopathies malignes. Partie I: patients [Autologous transplantation of peripheral blood hematopoietic stem cells in the treatment of hematological malignancies. I: patients]
Medinger, P., Tissot, J.D., Nicoloso de Faveri, G. +4 more